A simple trick that could prevent more than 20,000 cases of bowel cancer
The study, funded by Cancer Research UK, found that having an additional 300 milligrams of calcium every day (on top of the 700mg recommended by the NHS) could lower the risk of bowel cancer by 17 per ...
New colorectal cancer prediction test is more than 90% accurate
A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.
This groundbreaking method can predict bowel cancer with 90% accuracy, new research finds
This method will brings us closer to a potential blood test that could help doctors identify which IBD patients are most at ...
Can I reduce my risk of bowel cancer?
Around half of all bowel cancers could be prevented by having a healthier lifestyle, according to Bowel Cancer UK.
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel ...
Inflammatory Bowel Disease Market Set For Strong Growth By 2034, Predicts Delveinsight
DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...
Waterlooville man who lost his wife to bowel cancer welcomes research breakthrough
A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...
New bowel cancer detection method more than 90% accurate, research finds
A new method for detecting bowel cancer is more than 90% accurate at predicting which higher risk people will develop the ...
Algorithm study 90% accurate predicting bowel cancer
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Teva's Growth Profile Looks Strong From Innovative Portfolio, Biosimilar Approvals and Deep Pipeline
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...